BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36834574)

  • 1. Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein.
    Chen Y; Zhang R; Yang L; Zhang P; Wang F; Lin G; Zhang J; Zhu Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of the anti-angiogenesis effect of eltrombopag in breast cancer through targeting of HuR protein.
    Zhu Y; Yang L; Xu J; Yang X; Luan P; Cui Q; Zhang P; Wang F; Li R; Ding X; Jiang L; Lin G; Zhang J
    Acta Pharm Sin B; 2020 Aug; 10(8):1414-1425. PubMed ID: 32963940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human antigen R is positively associated with malignant aggressiveness via upregulation of cell proliferation, migration, and vascular endothelial growth factors and cyclooxygenase-2 in prostate cancer.
    Mitsunari K; Miyata Y; Asai A; Matsuo T; Shida Y; Hakariya T; Sakai H
    Transl Res; 2016 Sep; 175():116-28. PubMed ID: 27140699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression.
    Yang LQ; Yu SP; Yang YT; Zhao YS; Wang FY; Chen Y; Li QH; Tian P; Zhu YY; Zhang JG; Lin GQ
    Biomed Pharmacother; 2021 Apr; 136():111265. PubMed ID: 33450490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium.
    Kurosu T; Ohga N; Hida Y; Maishi N; Akiyama K; Kakuguchi W; Kuroshima T; Kondo M; Akino T; Totsuka Y; Shindoh M; Higashino F; Hida K
    Br J Cancer; 2011 Mar; 104(5):819-29. PubMed ID: 21285980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients.
    Giaginis C; Sampani A; Kotta-Loizou I; Giannopoulou I; Danas E; Politi E; Tsourouflis G; Kouraklis G; Patsouris E; Keramopoulos A; Nakopoulou L; Theocharis S
    Pathol Oncol Res; 2018 Jul; 24(3):631-640. PubMed ID: 28808873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
    Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
    Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer.
    Miyata Y; Watanabe S; Sagara Y; Mitsunari K; Matsuo T; Ohba K; Sakai H
    PLoS One; 2013; 8(3):e59095. PubMed ID: 23516604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.
    Denkert C; Koch I; von Keyserlingk N; Noske A; Niesporek S; Dietel M; Weichert W
    Mod Pathol; 2006 Sep; 19(9):1261-9. PubMed ID: 16799479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis.
    Blanco FF; Preet R; Aguado A; Vishwakarma V; Stevens LE; Vyas A; Padhye S; Xu L; Weir SJ; Anant S; Meisner-Kober N; Brody JR; Dixon DA
    Oncotarget; 2016 Nov; 7(45):74043-74058. PubMed ID: 27677075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
    Giaginis C; Alexandrou P; Tsoukalas N; Sfiniadakis I; Kavantzas N; Agapitos E; Patsouris E; Theocharis S
    Tumour Biol; 2015 Jan; 36(1):315-27. PubMed ID: 25252849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
    Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
    Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
    Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
    Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antigen R affects the migration and invasion of human lung cancer A549 cells via regulating E-cadherin suppressor Snail.
    Shan S; Bao Q; Ma G; Yao Y; Xiong J; You J
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):9-16. PubMed ID: 36227684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment.
    Kotta-Loizou I; Vasilopoulos SN; Coutts RH; Theocharis S
    Neoplasia; 2016 Nov; 18(11):674-688. PubMed ID: 27764700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
    Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.